Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Microvascular salvage of a thrombosed total ear replant
Senchenkov, Alex, Jacobson, Steven R.

Microsurgery | May 2, 2013 | Volume: 33 | Issue: 5 | Pages: 396-400

10.1002/micr.22100 | PMID 23640855 Get It

Microvascular replantation, when possible, is the treatment of choice for total ear amputations. Both arterial and venous reconstruction should be attempted. The present case report describes a successful total ear replantation in a 45‐year‐old woman whose ear was amputated due to a horse accident. Venous thrombosis subsequently occurred and was managed with anticoagulation and leech therapy. Eighty hours after the replantation, arterial thrombosis took place. The posterior auricular artery thrombosed anastomosis was resected and reconstructed with an interposition vein graft. This report illustrates the feasibility of the successful microvascular salvage of a thrombosed total ear replant. It suggests the need for close clinical monitoring of the replanted ear and prompt microvascular reexploration in an event of the loss of arterial flow. © 2013 Wiley Periodicals, Inc. Microsurgery 33:396–400, 2013.
Differences in rate of functional decline across three dementia types
Gill, Dawn P. , Hubbard, Rebecca A. , Koepsell, Thomas D., Borrie, Michael, Petrella, Robert J. , Kukull, Walter A. , Knopman, David S.

Alzheimer's & Dementia | May 2, 2013 | Volume: 9 | Issue: 5S | Pages: No page available

10.1016/j.jalz.2012.10.010 | PMID 23643459 Get It

BackgroundThe purpose of this study was to estimate differences in rates of functional decline in Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and vascular dementia (VaD) and whether differences vary by age or sex.MethodsData came from 32 U.S. Alzheimer's Disease Centers. The cohort of participants (n = 5848) were ≥60 years of age and had clinical dementia with a primary etiologic diagnosis of probable AD, DLB, or probable VaD; a Clinical Dementia Rating‐Sum of Boxes score <16; and a duration of symptoms ≤10 years. Dementia diagnoses were assigned using standard criteria. Annual mean rate of change of the Functional Activities Questionnaire (FAQ) score was modeled using multiple linear regression with generalized estimating equations adjusted for demographics, comorbidities, years since onset, and cognitive status (mean follow‐up = 2.0 years).ResultsFAQ declined more slowly over time in those with VaD compared with AD (difference in mean annual rate of change: −0.91; 95% confidence interval [CI]: −1.68, −0.14). VaD participants also declined at a slower rate than DLB participants, but this difference was not statistically significant (−0.61; 95% CI: −1.45, 0.24). There was no significant difference between DLB and AD. Within each group, rate of decline was more rapid for the youngest participants.ConclusionsIn this sample, findings suggested that VaD patients declined in their functional abilities at a slower rate compared with AD patients and that there were no significant differences in rate of functional decline between patients with DLB compared with those with either AD or VaD. These results may provide guidance to clinicians about average expected rates of functional decline in three common dementia types.
Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects
Pedraza, Otto , Allen, Mariet , Jennette, Kyle J. , Carrasquillo, Minerva M. , Serie, Daniel, Palusak, Ryan, Nguyen, Thuy , Malphrus, Kimberly G., Bisceglio, Gina, Roberts, Rosebud O., Lucas, John A. , Ivnik, Robert J., Smith, Glenn E. , Graff‐Radford, Neill R. , Petersen, Ronald C. , Younkin, Steven G., Ertekin‐Taner, Nilüfer , Carrasquillo, Minerva M. , Crook, Julia E. , Pankratz, V. Shane , Ma, Li

Alzheimer's & Dementia | May 2, 2013 | Volume: 10 | Issue: 2 | Pages: 205-213

10.1016/j.jalz.2013.01.016 | PMID 23643458 Get It

AbstractBackgroundGenetic variants at the CLU, CR1, and PICALM loci associate with risk for late‐onset Alzheimer's disease (LOAD) in genomewide association studies. In this study, our aim was to determine whether the LOAD risk variants at these three loci influence memory endophenotypes in black and white subjects.MethodsWe pursued an association study between single nucleotide polymorphism genotypes at the CLU, CR1, and PICALM loci and memory endophenotypes. We assessed black subjects (AA series: 44 with LOAD and 224 control subjects) recruited at Mayo Clinic Florida and whites recruited at Mayo Clinic Minnesota (RS series: 372 with LOAD and 1690 control subjects) and Florida (JS series: 60 with LOAD and 529 control subjects). Single nucleotide polymorphisms at the LOAD risk loci CLU (rs11136000), CR1 (rs6656401, rs3818361), and PICALM (rs3851179) were genotyped and tested for association with Logical Memory immediate recall, Logical Memory delayed recall, Logical Memory percent retention, Visual Reproduction immediate recall, Visual Reproduction delayed recall, and Visual Reproduction percent retention scores from the Wechsler Memory Scale–Revised using multivariable linear regression analysis, adjusting for age at exam, sex, education, and apolipoprotein E ε4 dosage.ResultsWe identified nominally significant or suggestive associations between the LOAD‐risky CR1 variants and worse Logical Memory immediate recall scores in blacks (P = .068–.046, β = −2.7 to −1.2). The LOAD‐protective CLU variant is associated with better logical memory endophenotypes in white subjects (P = .099–.027, β = 0.31–0.93). The CR1 associations persisted when the control subjects from the AA series were assessed separately. The CLU associations appeared to be driven by one of the white series (RS) and were also observed when the control subset from RS was analyzed.ConclusionThese results suggest for the first time that LOAD risk variants at CR1 may influence memory endophenotypes in blacks. In addition, the CLU LOAD‐protective variant may confer enhanced memory in whites. Although these results would not remain significant after stringent corrections for multiple testing, they need to be considered in the context of the LOAD associations with which they have biological consistency. They also provide estimates for effect sizes on memory endophenotypes that could guide future studies. The detection of memory effects for these variants in clinically normal subjects, implies that these LOAD risk loci might modify memory prior to clinical diagnosis of AD.
The Atrial Natriuretic Peptide Genetic Variant rs5068 Is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population
Cannone, Valentina , Cefalù, Angelo B. , Noto, Davide , Scott, Christopher G. , Bailey, Kent R. , Cavera, G., Sapienza, Michelangelo, Averna, Maurizio , Burnett, John C. , Pagano, Michele , Scott, Christopher

Diabetes Care | May 2, 2013 | Volume: 36 | Issue: 9 | Pages: 2850-2856

10.2337/dc12-2337 | PMID 23637347 Get It

OBJECTIVE We hypothesized that the minor allele of the atrial natriuretic peptide (ANP) genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a general Mediterranean population. RESEARCH DESIGN AND METHODS We genotyped a random sample of the residents of Ventimiglia di Sicilia, Sicily, for rs5068. RESULTS Genotype frequencies of rs5068 are AA, 93.5%; AG, 6.4%; and GG, 0.1%. All subsequent analyses are AA versus AG+GG. After adjusting for age and sex, the minor G allele is associated with lower BMI (estimate [SE]: −1.7 kg/m2 [0.8], P = 0.04). In the AG+GG group, males with HDL cholesterol levels &lt;40 mg/dL are less frequent (P = 0.05) and obesity tends to be less prevalent (P = 0.07). Importantly, the G allele is associated with a lower prevalence of metabolic syndrome (P = 0.02). After adjusting for BMI, the above associations were attenuated. Independently of age, sex, and BMI, the minor allele is also associated with lower systolic blood pressure (−6.0 mmHg [2.5], P = 0.02) and lower prevalence of hypertension (odds ratio 0.41 [95% CI 0.20–0.83], P = 0.01). CONCLUSIONS The association between the minor allele of rs5068 and a favorable cardiometabolic phenotype that we previously reported in a U.S. population is now replicated in a Mediterranean population in which the G allele of rs5068 is associated with lower blood pressure, BMI, and prevalence of hypertension and metabolic syndrome. These findings may lead to a diagnostic strategy to assess cardiometabolic risk and lay the foundation for the future development of an ANP or ANP-like therapy for metabolic syndrome.
Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy
Fujioka, Shinsuke , Algom, Avi A. , Murray, Melissa E. , Strongosky, Audrey , Soto‐Ortolaza, Alexandra I., Rademakers, Rosa , Ross, Owen A. , Dickson, Dennis W. , Soto‐Beasley, Alexandra I. , Wszołek, Zbigniew K. , Dickson, Dennis W , Ross, Owen A , Murray, Melissa E , Beasley, Alexandra I

Neurology | May 2, 2013 | Volume: 80 | Issue: 22 | Pages: 2076-2078

10.1212/wnl.0b013e318294b2eb | PMID 23635960 Get It

Identification of Novel Variants in Colorectal Cancer Families by High-Throughput Exome Sequencing
DeRycke, Melissa S. , Gunawardena, Shanaka R., Middha, Sumit , Asmann, Yan W. , Schaid, Daniel J. , McDonnell, Shannon K. , Riska, Shaun M., Eckloff, Bruce W., Cunningham, Julie M. , Serie, Daniel, Bamlet, William R. , Cicek, Mine S., Jenkins, Mark A. , Duggan, David , Buchanan, Daniel D. , Haile, Robert W. , Woods, Michael O. , Gallinger, Steven , Casey, Graham , Potter, John D. , Lindor, Noralane M. , Thibodeau, Stephen N. , Goode, Ellen L. , Fridley, Brooke L. , Clendenning, Mark , Newcomb, Polly A. , Marchand, Loı̈c Le , Buchanan, Daniel D , Jenkins, Mark A , Bamlet, William R , Haile, Robert W , Potter, John D , McDonnell, Shannon K

Cancer Epidemiology, Biomarkers & Prevention | May 2, 2013 | Volume: 22 | Issue: 7 | Pages: 1239-1251

10.1158/1055-9965.epi-12-1226 | PMID 23637064 Get It

Abstract Background: Colorectal cancer (CRC) in densely affected families without Lynch Syndrome may be due to mutations in undiscovered genetic loci. Familial linkage analyses have yielded disparate results; the use of exome sequencing in coding regions may identify novel segregating variants. Methods: We completed exome sequencing on 40 affected cases from 16 multicase pedigrees to identify novel loci. Variants shared among all sequenced cases within each family were identified and filtered to exclude common variants and single-nucleotide variants (SNV) predicted to be benign. Results: We identified 32 nonsense or splice-site SNVs, 375 missense SNVs, 1,394 synonymous or noncoding SNVs, and 50 indels in the 16 families. Of particular interest are two validated and replicated missense variants in CENPE and KIF23, which are both located within previously reported CRC linkage regions, on chromosomes 1 and 15, respectively. Conclusions: Whole-exome sequencing identified DNA variants in multiple genes. Additional sequencing of these genes in additional samples will further elucidate the role of variants in these regions in CRC susceptibility. Impact: Exome sequencing of familial CRC cases can identify novel rare variants that may influence disease risk. Cancer Epidemiol Biomarkers Prev; 22(7); 1239–51. ©2013 AACR.
Influence of fish oil on skeletal muscle mitochondrial energetics and lipid metabolites during high-fat diet
Błachnio‐Zabielska, Agnieszka , Schimke, Jill M. , Jakaitis, Daniel R. , Jensen, Michael D. , Lanza, Ian R. , Johnson, Matthew L. , LeBrasseur, Nathan K. , Nair, K. Sreekumaran , Zabielski, Piotr

American Journal of Physiology-Endocrinology and Metabolism | May 2, 2013 | Volume: 304 | Issue: 12 | Pages: E1391-E1403

10.1152/ajpendo.00584.2012 | PMID 23632634 Get It

Omega-3 polyunsaturated fatty acids (n-3 PUFAs) enhance insulin sensitivity and glucose homeostasis in rodent models of insulin resistance. These beneficial effects have been linked with anti-inflammatory properties, but emerging data suggest that the mechanisms may also converge on mitochondria. We evaluated the influence of dietary n-3 PUFAs on mitochondrial physiology and muscle lipid metabolites in the context of high-fat diet (HFD) in mice. Mice were fed control diets (10% fat), HFD (60% fat), or HFD with fish oil (HFD+FO, 3.4% kcal from n-3 PUFAs) for 10 wk. Body mass and fat mass increased similarly in HFD and HFD+FO, but n-3 PUFAs attenuated the glucose intolerance that developed with HFD and increased expression of genes that regulate glucose metabolism in skeletal muscle. Despite similar muscle triglyceride levels in HFD and HFD+FO, long-chain acyl-CoAs and ceramides were lower in the presence of fish oil. Mitochondrial abundance and oxidative capacity were similarly increased in HFD and HFD+FO compared with controls. Hydrogen peroxide production was similarly elevated in HFD and HFD+FO in isolated mitochondria but not in permeabilized muscle fibers, likely due to increased activity and expression of catalase. These results support a hypothesis that n-3 PUFAs protect glucose tolerance, in part by preventing the accumulation of bioactive lipid mediators that interfere with insulin action. Furthermore, the respiratory function of skeletal muscle mitochondria does not appear to be a major factor in sphingolipid accumulation, glucose intolerance, or the protective effects of n-3 PUFAs.
Meat-Related Mutagens and Pancreatic Cancer: Null Results from a Clinic-Based Case–Control Study
Jansen, Rick J. , Robinson, Dennis P. , Frank, Ryan D. , Bamlet, William R. , Oberg, Ann L. , Rabe, Kari G. , Petersen, Gloria M. , Anderson, Kristin E., Stolzenberg‐Solomon, Rachael Z. , Olson, Janet E. , Sinha, Rashmi R. , Chaffee, Kari G. , Bamlet, William R , Jansen, Rick J

Cancer Epidemiology, Biomarkers & Prevention | May 1, 2013 | Volume: 22 | Issue: 7 | Pages: 1336-1339

10.1158/1055-9965.epi-13-0343 | PMID 23632817 Get It

Abstract Background: Pancreatic cancer is a devastating disease for which the role of dietary factors remains inconclusive. The study objective was to evaluate risk of pancreatic cancer associated with meat preparation methods and meat-related mutagen consumption using a clinic-based case–control design. Methods: There were 384 cases and 983 controls; subjects provided demographic information and completed a 144-item food frequency questionnaire, which was used to estimate meat mutagen intake using the National Cancer Institute's CHARRED database (Bethesda, MD). Logistic regression was used to calculate ORs and 95% confidence intervals (CI), adjusted for factors including age, sex, cigarette smoking, body mass index, and diabetes mellitus. Results: Overall, the findings were null with respect to meat mutagen intake and pancreatic cancer. Conclusions: The results do not support an association between well-done meat or meat-related mutagen intake and pancreatic cancer and contrast with generally increased risks reported in previous studies. Impact: These data contribute to evidence about pancreatic cancer and potentially carcinogenic compounds in meat. Cancer Epidemiol Biomarkers Prev; 22(7); 1336–9. ©2013 AACR.
Intracranial hemorrhage from dural arteriovenous fistulas: clinical features and outcome
Vellimana, Ananth K. , Zipfel, Gregory J. , Daniels, David J. , Lanzino, Giuseppe

Neurosurgical Focus | May 1, 2013 | Volume: 34 | Issue: 5 | Pages: E15

10.3171/2013.4.focus1335 | PMID 23634919 Get It

Object In this paper the authors' goal was to review the clinical features and outcome of patients with intracranial dural arteriovenous fistulas (DAVFs) who presented with hemorrhage. Methods A retrospective study of 28 patients with DAVFs who presented with intracranial hemorrhage to 2 separate institutions was performed. The information reviewed included clinical presentation, location and size of hemorrhage, angiographic features, treatment, and clinical and radiologically documented outcomes. Clinical and radiological follow-up were available in 27 of 28 patients (mean follow-up 17 months). Results The vast majority of patients were male (86%), and the most common presenting symptom was sudden-onset headache. All DAVFs had cortical venous drainage, and about one-third were associated with a venous varix. The most common location was tentorial (75%). Treatment ranged from endovascular (71%), surgical (43%), Gamma Knife surgery (4%), or a combination of modalities. The majority of fistulas (75%) were completely obliterated, and most patients experienced excellent clinical outcome (71%, modified Rankin Scale score of 0 or 1). There were no complications in this series. Conclusions Case series, including the current one, suggest that the vast majority of patients who present with intracranial hemorrhage from a DAVF are male. The most common location for DAVFs presenting with hemorrhage is tentorial. Excellent outcomes are achieved with individualized treatment, which includes various therapeutic strategies alone or in combination. Despite the hemorrhagic presentation, almost two-thirds of patients experience a full recovery with no or minimal residual symptoms.
Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma
Roemeling, Christina A. Von , Marlow, Laura A. , Wei, Johnny J. , Caulfield, Thomas R. , Wu, Kevin J. , Tan, Winston , Copland, John A. , Cooper, Simon JR , Tun, Han W. , Caulfield, Thomas R , von Roemeling, Christina A , Marlow, Laura

Clinical Cancer Research | May 1, 2013 | Volume: 19 | Issue: 9 | Pages: 2368-2380

10.1158/1078-0432.ccr-12-3249 | PMID 23633458 Get It

Abstract Purpose: We set out to identify Stearoyl-CoA desaturase 1 (SCD1) as a novel molecular target in clear cell renal cell carcinoma (ccRCC) and examine its role in tumor cell growth and viability in vitro and in vivo independently as well as in combination with current U.S. Food and Drug Administration (FDA)-approved regimens. Experimental Design: Patient normal and ccRCC tissue samples and cell lines were examined for SCD1 expression. Genetic knockdown models and targeted inhibition of SCD1 through use of a small molecule inhibitor, A939572, were analyzed for growth, apoptosis, and alterations in gene expression using gene array analysis. Therapeutic models of synergy were evaluated utilizing pharmacologic inhibition of SCD1 with the tyrosine kinase inhibitors (TKI) sunitinib and pazopanib, and the mTOR inhibitor temsirolimus. Results: Our studies identify increased SCD1 expression in all stages of ccRCC. Both genetic knockdown and pharmacologic inhibition of SCD1 decreased tumor cell proliferation and induced apoptosis in vitro and in vivo. Upon gene array, quantitative real-time PCR, and protein analysis of A939572-treated or SCD1 lentiviral knockdown samples, induction of endoplasmic reticulum stress response signaling was observed, providing mechanistic insight for SCD1 activity in ccRCC. Furthermore, combinatorial application of A939572 with temsirolimus synergistically inhibited tumor growth in vitro and in vivo. Conclusions: Increased SCD1 expression supports ccRCC viability and therefore we propose it as a novel molecular target for therapy either independently or in combination with an mTOR inhibitor for patients whose disease cannot be remedied with surgical intervention, such as in cases of advanced or metastatic disease. Clin Cancer Res; 19(9); 2368–80. ©2013 AACR.